MAPT and Alzheimer disease: Evidence that senolytic intervention may be an effective treatment for AD was first reported in tau transgenic mice models of frontotemporal dementia (FTD; Bussian et al., 2018; Musi et al., 2018), which do not present amyloid plaques but are arguably an AD-like tau pathology model.